Hyatt Andrew S, Overhage Lindsay, Cook Benjamin Lê
Health Equity Research Lab, Cambridge Health Alliance, Cambridge, Massachusetts.
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
JAMA Netw Open. 2025 Jul 1;8(7):e2520093. doi: 10.1001/jamanetworkopen.2025.20093.
Cannabis use has been shown to modestly increase shortly after legalization of recreational use, but little is known about longer-term changes in cannabis and tobacco use.
To assess the association of cannabis legalization and commercialization with the use of cannabis, cigarettes, and electronic nicotine delivery systems (ENDS) in the 5 years after legalization in the US.
DESIGN, SETTING, AND PARTICIPANTS: The Population Assessment of Tobacco and Health (PATH) study, a nationally representative longitudinal cohort study of adults 18 years or older in the US, was used for a retrospective, difference-in-differences analysis of panel data from January 2013 to December 2022. Data were analyzed from May 8, 2024, to April 20, 2025.
State-level recreational cannabis legalization (RCL) and opening of retail outlets with 5 years of follow-up.
Percentage point changes in 30-day use of cannabis, cigarettes, and ENDS in states with legalization compared with control states, aggregated over 5 years and then broken down into the periods before and after retail outlets opened.
Among the 171 257 observations from 55 406 individuals included in the analysis (50.9% female; mean [SD] age, 37.97 [17.69] years), RCL was associated with an increase of cannabis use by 3.28 (95% CI, 2.29-4.27) percentage points and ENDS use by 1.39 (95% CI, 0.44-2.35) percentage points compared with control states. There was no differential change in cigarette use (-0.99 [95% CI, -2.25 to 0.27] percentage points). For cannabis, this change was greater after retail outlets opened (3.74 [95% CI, 2.65-4.82] percentage points) compared with before (1.17 [95% CI, 0.13-2.20] percentage points). There were no large changes in ENDS or cigarette use associated with the opening of retail outlets.
In this longitudinal cohort study, RCL was associated with more cannabis and ENDS use after 5 years and no significant change in cigarette use. Furthermore, cannabis use increased over time, underscoring the importance of studying commercialization policy going forward. Based on the present results, it is unlikely RCL has been associated with a large increase in cigarette use, but increases in use of cannabis and vaped nicotine bear close monitoring as retail cannabis rapidly expands.
研究表明,娱乐用大麻合法化后不久,其使用量会略有增加,但对于大麻和烟草使用的长期变化知之甚少。
评估美国大麻合法化和商业化与合法化后5年内大麻、香烟及电子尼古丁传送系统(ENDS)使用之间的关联。
设计、背景和参与者:烟草与健康人口评估(PATH)研究是一项针对美国18岁及以上成年人的具有全国代表性的纵向队列研究,用于对2013年1月至2022年12月的面板数据进行回顾性差异分析。数据于2024年5月8日至2025年4月20日进行分析。
州级娱乐用大麻合法化(RCL)及零售门店开业,并进行5年随访。
与对照州相比,合法化州大麻、香烟和ENDS的30天使用量变化的百分点,汇总5年数据,然后再细分为零售门店开业前后的时间段。
纳入分析的55406名个体的共171257条观察数据中(50.9%为女性;平均[标准差]年龄为37.97[17.69]岁),与对照州相比,RCL与大麻使用量增加3.28(95%置信区间,2.29 - 4.27)个百分点以及ENDS使用量增加1.39(9�%置信区间,0.44 - 2.35)个百分点相关。香烟使用量无差异变化(-0.99[95%置信区间,-2.25至0.27]个百分点)。对于大麻,零售门店开业后的变化(3.74[95%置信区间,2.65 - 4.82]个百分点)大于开业前(1.17[95%置信区间,0.13 - 2.20]个百分点)。零售门店开业与ENDS或香烟使用量的大幅变化无关。
在这项纵向队列研究中,RCL与5年后更多的大麻和ENDS使用相关,而香烟使用量无显著变化。此外,大麻使用量随时间增加,凸显了研究未来商业化政策的重要性。根据目前的结果,RCL不太可能与香烟使用量的大幅增加相关,但随着零售大麻迅速扩张,大麻和雾化尼古丁使用量的增加值得密切监测。